Novel drug delivery methods are rapidly growing in number and type. Some of the intended areas of improvement, without excluding others, are sustained release, targeted delivery, enhanced absorption/transport, constant and controllable release through implants, pulmonary systemic delivery, advanced transdermal/transmuscular delivery, sublingual and inguinal delivery, peritoneal delivery, remote actuation, and bioavailability enhancement. While many technologies have been in use for decades, effective use of the right method for the application and drug of interest is the grand challenge. The focus of this session is on innovative design of drug delivery devices and/or the development of associated formulations. Topics of special interest are device development, device performance, intentional formulation development for a specific device, issues surrounding the device-formulation integration, and quantification of the device-formulation-tissue interaction. Papers covering experimental results or modeling of device performance are welcome, but those correlating data with theory are of greatest interest.

Pharmaceuticals